Biotech Analysts Minter and Schram, along with CEO Monia discuss the company’s clinical capabilities as a leader in the RNA-targeted therapeutics space with a focus on key near-term events on a conference call to be held on December 12 at 12:30 pm hosted by William Blair. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IONS:
- Ionis Pharmaceuticals management to meet with Oppenheimer
- Ionis Pharmaceuticals files automatic common stock offering
- Ionis Pharmaceuticals management to meet with Needham
- Ionis shares clinical update from ongoing trial of ION582 for Angelman syndrome
- Ionis reports ‘positive’ two-year results from Phase 2 OLE study of donidalorsen